Cytokinetics Incorporated (NASDAQ:CYTK) and INSYS Therapeutics Inc. (NASDAQ:INSY), both competing one another are Biotechnology companies. We will compare their risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation.
Earnings and Valuation
We can see in table 1 the earnings per share, top-line revenue and valuation of Cytokinetics Incorporated and INSYS Therapeutics Inc.
Table 2 shows us the return on assets, net margins and return on equity of both companies.
Volatility and Risk
Cytokinetics Incorporated has a beta of 2.04 and its 104.00% more volatile than Standard and Poor’s 500. INSYS Therapeutics Inc.’s 156.00% more volatile than Standard and Poor’s 500 volatility due to the stock’s 2.56 beta.
The Current Ratio and a Quick Ratio of Cytokinetics Incorporated are 10.6 and 10.6. Competitively, INSYS Therapeutics Inc. has 0.7 and 0.6 for Current and Quick Ratio. Cytokinetics Incorporated’s better ability to pay short and long-term obligations than INSYS Therapeutics